The aim of the present study was to describe the molecular epidemiology of PIK3CA and PIK3R1 mutations in a large, real-life cohort of patients treated for cancer, whatever the cancer type, and who had tumor exome analysis performed by Next Generation Sequencing (NGS) at the Centre George François Leclerc, Dijon, France. The gene discussed is PIK3CA; the disease is cancer.